Following the announcement of EnergyPathways’ £15 million financing package with a “global institutional investor”, some have questioned whether the facility resembles the so-called “death spiral” financing structures that have historically damaged shareholder value at a number of small-cap companies.
A detailed examination of the terms suggests that the answer is a clear NO.
In fact, many of the key features of the EnergyPathways facility are specifically structured to align the investor’s interests with those of existing shareholders and to support the long-term development of the Company’s nationally significant MESH energy storage project.
What Is Death Spiral Finance?
Death spiral financing is a term coined to describe a financing structure where an investor provides capital through a type of loan instrument that can be converted into shares at a discount to the prevailing market price.
The lower the share price falls, the more shares the investor receives upon conversion.
In a traditional death spiral structure, this can create a negative feedback loop:
- The investor converts debt at a discount to the prevailing market price.
- As the share price falls, the investor receives more shares.
- The investor can profit from selling shares and pushing the price lower.
- The process repeats itself, driving the share price lower and lower.
- Shareholder dilution accelerates as the stock declines.
In extreme cases, the investor continues to benefit from a falling share price because lower prices result in more shares being issued.
This is why such structures are often referred to as “toxic” or “death spiral” financing.
Why EnergyPathways’ Facility Is Different:
The most important distinction is simple:
The investor cannot convert at a discount to the market price.
Under the EnergyPathways financing deal, conversion is only possible at a price equal to the Reference Price plus a 40% premium.
This means that if the Company’s shares are trading at 10p when a drawdown occurs, the investor’s conversion price becomes 14p.
Unlike a traditional death spiral structure, if the share price subsequently falls, the investor does not receive additional shares through a lower conversion price.
The investor therefore has no economic incentive to benefit from a declining share price.
Indeed, the opposite is true.
The investor benefits most if the share price rises substantially above the conversion price.
A Rare Feature: Conversion at a Premium
AIM investors are accustomed to seeing financing announced at discounts to the prevailing market price.
EnergyPathways has instead secured a facility where both conversion rights and associated warrants are priced at a 40% premium to the reference share price.
It means the investor’s upside is linked to value creation rather than dilution.
In effect, the financing partner is backing the MESH project in the belief that it can create significantly greater shareholder value over time.
To clarify:
The first tranche of £1 million was drawn down on 30th April 2026
Associated warrants of circa 5 million were issued with an exercise price of 8.30p; a 40% premium to the reference price of 5.93 pence.
A second tranche of £1 million was then drawn down on 2nd June 2026
This time, associated warrants of circa 3.4 million were issued with an exercise price of 12.24p; a 40% premium to the reference price of 8.74 pence. (No warrants have been exercised to date.)
So, as long as the company manages the drawdowns intelligently, the exercise price will continue to rise whilst the equivalent associated warrants continue to decrease.
Strong Protections Against Market Pressure
Another characteristic often associated with toxic financing arrangements is the ability of the investor to place shares into the market at discounts.
EnergyPathways’ facility explicitly protects against this.
The ATM Facility states that shares sold by the investor cannot be placed below the Company’s prevailing market price.
Furthermore, sales are subject to volume limitations, as the total shares issued are capped at no more than 2.99% of the company’s outstanding shares. There are also dealing restrictions and orderly market provisions in place.
It’s also worth noting that all CLN and ATM drawdowns are entirely at the company’s discretion.
These protections are designed to minimise disruption to normal market trading and reduce the risk of excessive downward pressure on the share price.
Flexible Capital for a Transformational Project
Securing access to £15 million of capital in the current funding environment is a significant achievement for any pre-revenue energy infrastructure developer. But perhaps the most important aspect of the facility is the flexibility it provides.
The Company now has access to:
* Up to £5 million through the secured Loan.
* Up to £10 million through the ATM Facility.
* A three-year funding runway.
* Company-controlled drawdowns.
* Funding available as project milestones are achieved.
This means EnergyPathways can access capital when required rather than raising substantial equity at a potentially discounted valuation via placings.
For existing shareholders, that flexibility can be highly valuable as the Company advances permitting, FEED activities, strategic partnerships and project financing discussions relating to MESH.
It also rules out the risk of a discount AIM retail cash raise.
Alignment of Interests
A useful way to evaluate any financing package is to ask a simple question:
Does the investor benefit when shareholders benefit?
In many toxic financing structures, the answer is often no.
In the EnergyPathways structure, however, the investor’s conversion rights and warrants become most valuable when the Company’s share price appreciates materially.
That creates a much closer alignment between the financing partner and existing shareholders.
The investoris effectively incentivised to support the long-term success of the Company rather than exploit short-term share price weakness.
Putting the 40% Premium into Context
Perhaps the most overlooked aspect of the EnergyPathways financing package is the pricing of the conversion rights and warrants.
Across the AIM market, companies frequently raise capital through placings conducted at discounts to the prevailing share price. Depending on market conditions, discounts of between 5% and 25% are commonplace, with larger discounts often required when market sentiment is weak, or funding is urgently needed.
Against that backdrop, EnergyPathways’ financing stands out.
Rather than securing the right to convert at a discount, the investor’s conversion rights are exercisable at a price equal to the Reference Price plus a 40% premium. The warrants issued alongside the facility are also exercisable at the same 40% premium.
This distinction is significant.
A conventional discounted financing rewards an investor immediately upon completion of the transaction. By contrast, a conversion price set 40% above the reference share price only becomes economically attractive if the Company succeeds in creating substantial shareholder value.
In simple terms, the investor’s potential upside is directly linked to appreciation in the Company’s share price.
For example, if the Reference Price at drawdown was 10p, the conversion and warrant exercise price would be 14p. Existing shareholders would therefore only experience conversion-related dilution if the Company’s share price had risen materially above the original reference level.
Viewed through this lens, the financing can be seen as a strong endorsement of the long-term value potential of the MESH project. The investor has accepted a structure where its greatest rewards are achieved not through discounted conversions or falling share prices, but through the successful development of the project and a higher future valuation for the Company.
At a time when many development-stage companies are forced to accept heavily discounted finance, securing access to up to £15 million of capital with conversion rights and warrants priced at a 40% premium represents a noteworthy achievement and reflects a financing structure that is unusually aligned with the interests of existing shareholders. What makes this deal even more unique is that at the time the £15m finance deal was signed, EnergyPathway’s market capitalisation was a mere £12.5m.
It would appear that the CEO, Ben Clube’s previous experience as Vice President of Finance at BHP Petroleum has certainly helped in the case.
For investors evaluating the financing package, the key takeaway is clear:
This is not a traditional convertible financing structure. Rather, it is a growth-focused funding package designed to provide development capital while maintaining meaningful alignment between the investor and existing shareholders.
That being said, when alternative DEVEX or CAPEX funding lands from the government or private sector partners, this finance package most likely will become redundant anyway.
Of course, please do your own research and read back through the past year’s RNS’s carefully and scour the new corporate investor presentation (link below), as it’s in the detail that the real value proposition of MESH is clear.
Link to Corporate Presentation: Here
